Kera Capital Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Kera Capital Partners, Inc.
- $347 Billion
- Q4 2024
A detailed history of Kera Capital Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 1,332 shares of CRL stock, worth $210,789. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,332Holding current value
$210,789% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$975 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$805 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$345 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$286 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$286 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.05B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...